2015
DOI: 10.1097/wnf.0000000000000106
|View full text |Cite
|
Sign up to set email alerts
|

Are Second-Generation Antipsychotics Useful in Tardive Dystonia?

Abstract: The available evidence points to the effectiveness of clozapine as monotherapy and in combination with clonazepam for the treatment of TDt. When clozapine is not an option, olanzapine and quetiapine are reasonable alternatives. Given the lack of controlled trials, future focus should be on conducting randomized, placebo-controlled, multicenter, collaborative controlled clinical trials of several years' duration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 104 publications
(109 reference statements)
0
14
0
Order By: Relevance
“…S24 A combination of clozapine with diazepam showed clear improvement on the BFMDRS. S28 Furthermore, the combination with clonazepam has been shown to be an effective treatment option in some patients, S11,S14 as also reported by Pinninti et al …”
Section: Resultsmentioning
confidence: 80%
See 1 more Smart Citation
“…S24 A combination of clozapine with diazepam showed clear improvement on the BFMDRS. S28 Furthermore, the combination with clonazepam has been shown to be an effective treatment option in some patients, S11,S14 as also reported by Pinninti et al …”
Section: Resultsmentioning
confidence: 80%
“…S24 A combination of clozapine with diazepam showed clear improvement on the BFMDRS. S28 Furthermore, the combination with clonazepam has been shown to be an effective treatment option in some patients, S11,S14 as also reported by Pinninti et al 33 Another dopamine receptor blocker is quetiapine, which is an atypical antipsychotic similar to clozapine. Nineteen patients with tardive dystonia achieved long-lasting benefit from treatment with this drug.…”
Section: Dopamine-altering Agentsmentioning
confidence: 88%
“…Conflicting data revealed benefits in some studies, particularly in tardive dystonia [146, 155157], but not in others [158, 159]. The use of the DRBAs as routine treatment for dystonia is generally discouraged due to the risk of engendering tardive syndromes [7, 160162].…”
Section: Reviewmentioning
confidence: 99%
“…The jury is not fully in this regard but studies such as CATIE have enlightened a little [208][209][210][211][212][213]. I postulate that ultimately there will be a differential risk for TD amongst these SGAs partly based on higher selectivity for the Dopamine 2 or 2/3 receptors compared with the dopamine 1 family [214][215][216][217][218].…”
Section: Lower Risk Neurolepticsmentioning
confidence: 99%
“…However, there are often contradictions. It's interesting looking at the early work and predictions on TD [200,234,[238][239][240][241][242][243][244][245][246][247][248][249][250] compared with the most recent ideas [20,48,101,152,154,210,211,[216][217][218][219]. These latter ideas have taken into account clarity on genes and genetics of TD where at best the jury is undecided, and also still show contradictory data.…”
Section: Perspectivementioning
confidence: 99%